Author: GlobeNewswire

FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) — Statera Biopharma (Nasdaq: STAB) (the “Company”), a leading biopharmaceutical company creating…

TORONTO, April 26, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX:ASP; OTCQB:ASPCF) announced that further to…

JERSEY CITY, N.J., April 26, 2022 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the closing of its previously…

MISSISSAUGA, Ontario, April 26, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it…

EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) —  Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today…

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company…

BOSTON, April 26, 2022 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that the company will host a…

JSP191 is well tolerated with no treatment-related severe adverse events in 24 patients with myelodysplastic syndrome (MDS) or acute myeloid…

Rezolute to host conference call presentation and discussion of the data on Sunday, May 1 at 2:30 p.m. ET REDWOOD…

Mechelen, Belgium; 26 April 2022, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces that the proposed resolutions presented…